Outset Medical (OM)
(Delayed Data from NSDQ)
$3.85 USD
-0.02 (-0.52%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $4.11 +0.26 (6.75%) 6:42 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OM 3.85 -0.02(-0.52%)
Will OM be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for OM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OM
Outset Medical (OM) Upgraded to Buy: What Does It Mean for the Stock?
Outset Medical, Inc. (OM) Reports Q1 Loss, Misses Revenue Estimates
OM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis
Inspire (INSP) Surges 9.9%: Is This an Indication of Further Gains?
Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy?
Other News for OM
Osisko Metals Releases 2024 Pine Point Mineral Resource Estimate: 49.5Mt of Indicated Mineral Resources Grading 5.52% ZnEq and 8.3Mt of Inferred Mineral Resources Grading 5.64% ZnEq
Osisko Metals Unveils Robust Pine Point Estimates
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Outset Medical, up 15% following upgrade from RBC Capital Markets
Outset Medical up 15% following upgrade from RBC Capital Markets